Therefore, in 2014, Torres-Mejia et al., performed a molecular analysis of recurrent mutations in BRCA1/BRCA2 in 810 unselected breast cancer patients, residents of three Mexican cities (Mexico City, Veracruz and Monterrey). This evidence concerns the gene BRCA1 and breast carcinoma.